Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy

被引：23

作者：

Huober, Jens ^{[1
,2
]}

van Mackelenbergh, Marion ^{[3
]}

Schneeweiss, Andreas ^{[4
]}

Seither, Fenja ^{[5
]}

Blohmer, Jens-Uwe ^{[6
,7
]}

Denkert, Carsten ^{[8
]}

Tesch, Hans ^{[9
]}

Hanusch, Claus ^{[10
]}

Salat, Christoph ^{[11
]}

Rhiem, Kerstin ^{[12
]}

Solbach, Christine ^{[13
]}

Fasching, Peter A. ^{[14
]}

Jackisch, Christian ^{[15
]}

Reinisch, Mattea ^{[16
]}

Lederer, Bianca ^{[5
]}

Mehta, Keyur ^{[5
]}

Link, Theresa ^{[17
]}

Nekljudova, Valentina ^{[5
]}

Loibl, Sibylle ^{[5
]}

Untch, Michael ^{[18
]}

机构：

[1] Univ Frauenklin Ulm, Brustzentrum, Ulm, Germany

[2] Kantonsspital St Gallen, Brustzentrum, Dept Interdisziplinare Med Dienste, St Gallen, Switzerland

[3] Univ Klinikum Schleswig Holstein, Brustzentrum, Campus Kiel,Arnold Heller Str 3, D-24105 Kiel, Germany

[4] Natl Ctr Tumorerkrankungen, Heidelberg, Germany

[5] German Breast Grp, Neu Isenburg, Germany

[6] Charite Univ Med Berlin, Gynakol, Berlin, Germany

[7] Charite Univ Med Berlin, Brustzentrum, Berlin, Germany

[8] Philipps Univ Marburg, Inst Pathol, Marburg, Germany

[9] Ctr Hamatol & Onkol Bethanien Frankfurt, Frankfurt, Germany

[10] Klinikum Roten Kreuz Munchen, Munich, Germany

[11] Hamatol Onkol Schwerpunktpraxis Salat Stotzer, Munich, Germany

[12] Uniklin Koln, Zentrum Familiarer Brust & Eierstockkrebs, Cologne, Germany

[13] Univ Klinikum Frankfurt, Frankfurt, Germany

[14] Univ Klinikum Erlangen, Erlangen, Germany

[15] Sana Klinikum Offenbach, Offenbach, Germany

[16] Evang Kliniken Essen Mitte, Essen, Germany

[17] Tech Univ Dresden, Dept Gynecol & Obstet, Dresden, Germany

[18] HELIOS Klinikum Berlin Buch, Berlin, Germany

来源：

NPJ BREAST CANCER | 2023年 / 9卷 / 01期

关键词：

TAXANE-BASED CHEMOTHERAPY; STAGING SYSTEM; CAPECITABINE; BEVACIZUMAB; SURVIVAL; GEPARQUINTO; OUTCOMES; TRASTUZUMAB; CARBOPLATIN; EVEROLIMUS;

D O I：

10.1038/s41523-023-00525-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This retrospective pooled analysis aims to identify factors predicting relapse despite a pathologic complete response (pCR) in patients with breast cancer (BC). 2066 patients with a pCR from five neoadjuvant GBG/AGO-B trials fulfill the inclusion criteria of this analysis. Primary endpoint is disease-free survival (DFS); secondary endpoints is distant DFS (DDFS) and overall survival (OS). After a median follow-up of 57.6 months, DFS is significantly worse for patients with positive lymph nodes (cN+ vs cN0 hazard ratio [HR] 1.94, 95%CI 1.48-2.54; p < 0.001). In patients with triple-negative tumors, lobular histology (lobular vs other HR 3.55, 95%CI 1.53-8.23; p = 0.003), and clinical nodal involvement (cN+ vs cN0 HR 2.45, 95%CI 1.59-3.79; p < 0.001) predict a higher risk of DFS events. Patients with HER2-positive cT3/4 tumors have a significantly higher risk of relapse (cT3/4 vs cT1 HR 2.07, 95%CI 1.06-4.03; p = 0.033). Initial tumor load and histological type predict relapse in patients with a pCR.

引用

页数：12

共 39 条

[21] Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy [J].

Masuda, N. ;

Lee, S. -J. ;

Ohtani, S. ;

Im, Y. -H. ;

Lee, E. -S. ;

Yokota, I. ;

Kuroi, K. ;

Im, S. -A. ;

Park, B. -W. ;

Kim, S. -B. ;

Yanagita, Y. ;

Ohno, S. ;

Takao, S. ;

Aogi, K. ;

Iwata, H. ;

Jeong, J. ;

Kim, A. ;

Park, K. -H. ;

Sasano, H. ;

Ohashi, Y. ;

Toi, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (22) :2147-2159

[22] Validation of a Novel Staging System for Disease-Specific Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy [J].

Mittendorf, Elizabeth A. ;

Jeruss, Jacqueline S. ;

Tucker, Susan L. ;

Kolli, Aparna ;

Newman, Lisa A. ;

Gonzalez-Angulo, Ana M. ;

Buchholz, Thomas A. ;

Sahin, Aysegul A. ;

Cormier, Janice N. ;

Buzdar, Aman U. ;

Hortobagyi, Gabriel N. ;

Hunt, Kelly K. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :1956-1962

[23] Predictors of pathological complete response to neoadjuvant chemotherapy in stage II and III breast cancer: The impact of chemotherapeutic regimen [J].

Nwaogu, Iheoma Y. ;

Fayanju, Oluwadamilola M. ;

Jeffe, Donna B. ;

Margenthaler, Julie A. .

MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (05) :1117-1122

[24] 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years [J].

Pan, Hongchao ;

Gray, Richard ;

Braybrooke, Jeremy ;

Davies, Christina ;

Taylor, Carolyn ;

McGale, Paul ;

Peto, Richard ;

Pritchard, Kathleen I. ;

Bergh, Jonas ;

Dowsett, Mitch ;

Hayes, Daniel F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (19) :1836-1846

[25] Clinical implications of the intrinsic molecular subtypes of breast cancer [J].

Prat, Aleix ;

Pineda, Estela ;

Adamo, Barbara ;

Galvan, Patricia ;

Fernandez, Aranzazu ;

Gaba, Lydia ;

Diez, Marc ;

Viladot, Margarita ;

Arance, Ana ;

Munoz, Montserrat .

BREAST, 2015, 24 :S26-S35

[26] Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial [J].

Riethdorf, Sabine ;

Mueller, Volkmar ;

Loibl, Sibylle ;

Nekljudova, Valentina ;

Weber, Karsten ;

Huober, Jens ;

Fehm, Tanja ;

Schrader, Iris ;

Hilfrich, Joern ;

Holms, Frank ;

Tesch, Hans ;

Schem, Christian ;

von Minckwitz, Gunter ;

Untch, Michael ;

Pantel, Klaus .

CLINICAL CANCER RESEARCH, 2017, 23 (18) :5384-5393

[27] Relapsed Classic E-Cadherin (CDH1)-Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene Mutations [J].

Ross, Jeffrey S. ;

Wang, Kai ;

Sheehan, Christine E. ;

Boguniewicz, Ann B. ;

Otto, Geoff ;

Downing, Sean R. ;

Sun, James ;

He, Jie ;

Curran, John A. ;

Ali, Siraj ;

Yelensky, Roman ;

Lipson, Doron ;

Palmer, Gary ;

Miller, Vincent A. ;

Stephens, Philip J. .

CLINICAL CANCER RESEARCH, 2013, 19 (10) :2668-2676

[28] NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69-GeparSepto [J].

Untch, Michael ;

Jackisch, Christian ;

Schneeweiss, Andreas ;

Schmatloch, Sabine ;

Aktas, Bahriye ;

Denkert, Carsten ;

Schem, Christian ;

Wiebringhaus, Hermann ;

Kuemmel, Sherko ;

Warm, Mathias ;

Fasching, Peter A. ;

Just, Marianne ;

Hanusch, Claus ;

Hackmann, John ;

Blohmer, Jens-Uwe ;

Rhiem, Kerstin ;

Schmitt, Wolfgang D. ;

Furlanetto, Jenny ;

Gerber, Bernd ;

Huober, Jens ;

Nekljudova, Valentina ;

von Minckwitz, Gunter ;

Loibl, Sibylle .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (25) :2226-+

[29] Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial [J].

Untch, Michael ;

Loibl, Sibylle ;

Bischoff, Joachim ;

Eidtmann, Holger ;

Kaufmann, Manfred ;

Blohmer, Jens-Uwe ;

Hilfrich, Joern ;

Strumberg, Dirk ;

Fasching, Peter A. ;

Kreienberg, Rolf ;

Tesch, Hans ;

Hanusch, Claus ;

Gerber, Bernd ;

Rezai, Mahdi ;

Jackisch, Christian ;

Huober, Jens ;

Kuehn, Thorsten ;

Nekljudova, Valentina ;

von Minckwitz, Gunter .

LANCET ONCOLOGY, 2012, 13 (02) :135-144

[30] Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer [J].

von Minckwitz, G. ;

Huang, C. -S. ;

Mano, M. S. ;

Loibl, S. ;

Mamounas, E. P. ;

Untch, M. ;

Wolmark, N. ;

Rastogi, P. ;

Schneeweiss, A. ;

Redondo, A. ;

Fischer, H. H. ;

Jacot, W. ;

Conlin, A. K. ;

Arce-Salinas, C. ;

Wapnir, I. L. ;

Jackisch, C. ;

DiGiovanna, M. P. ;

Fasching, P. A. ;

Crown, J. P. ;

Wuelfing, P. ;

Shao, Z. ;

Caremoli, E. Rota ;

Wu, H. ;

Lam, L. H. ;

Tesarowski, D. ;

Smitt, M. ;

Douthwaite, H. ;

Singel, S. M. ;

Geyer, C. E., Jr. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (07) :617-628

← 1 2 3 4 →